# BUTALBITAL, ASPIRIN AND CAFFEINE
> **ANDA205230** · Abbreviated New Drug Application (Generic) · Sponsor: LGM PHARMA · Approved 2021-10-18
## Drug
- **FDA Application Number:** ANDA205230
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUTALBITAL, ASPIRIN AND CAFFEINE
- **Generic name:** BUTALBITAL, ASPIRIN, AND CAFFEINE
- **Active ingredients:** ASPIRIN; BUTALBITAL; CAFFEINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LGM PHARMA
- **Manufacturer:** LGM PHARMA SOLUTIONS, LLC
- **First approval:** 2021-10-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205230)
---
*MORVS · CC0 1.0*